The impact of glycosylation on the biological function and structure of human immunoglobulins

Annual Review of Immunology

Volumn 25, Issue , 2007, Pages 21-50

  Arnold, James N ^a,b   Wormald, Mark R ^a   Sim, Robert B ^b   Rudd, Pauline M ^a   Dwek, Raymond A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Fc receptors; Glycoforms; Mannan binding lectin; Rheumatoid arthritis

Indexed keywords

ALEMTUZUMAB; ASPARAGINE LINKED OLIGOSACCHARIDE; EPITOPE; GALECTIN 3; GLYCAN; GLYCOPROTEIN; GLYCOPROTEIN GP 120; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A1; IMMUNOGLOBULIN A2; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN M; LECTIN; OLIGOSACCHARIDE; SUGAR;

ADAPTIVE IMMUNITY; ANTIBODY STRUCTURE; ANTIGEN BINDING; AUTOIMMUNE DISEASE; CRYSTAL STRUCTURE; DATA BASE; DIMERIZATION; DISEASE ACTIVITY; FOLLICULAR LYMPHOMA; GLYCOBIOLOGY; GLYCOSYLATION; GRAFT REJECTION; HINGE EXON; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN PRODUCTION; IMMUNOGLOBULIN STRUCTURE; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; LEUKEMIA; LYMPHOMA; MOLECULAR DYNAMICS; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN CROSS LINKING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; RHEUMATOID ARTHRITIS;

ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; CARBOHYDRATE SEQUENCE; DATABASES, PROTEIN; EPITOPES; GLYCOSYLATION; HUMANS; IMMUNOGLOBULINS; MODELS, MOLECULAR; OLIGOSACCHARIDES; PROTEIN MODIFICATION, TRANSLATIONAL; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 34247122497     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.25.022106.141702     Document Type: Review

References (143)

1. Dwek RA, Jones R, Marsh D, McLaughlin AC, Press EM, et al. 1975. Antibody-hapten interactions in solution. Philos. Trans. R. Soc. London B Biol. Sci. 272:53-74
2. Dwek RA, Wain-Hobson S, Dower S, Gettins P, Sutton B, et al. 1977. Structure of an antibody combining site by magnetic resonance. Nature 266:31-37
3. Dwek RA. 1995. Glycobiology: "towards understanding the function of sugars." Biochem. Soc. Trans. 23:1-25
4. Deisenhofer J. 1981. Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9-and 2.8-Å resolution. Biochemistry 20:2361-70
5. Parekh RB, Dwek RA, Sutton BJ, Fernandes DL, Leung A, et al. 1985. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature 316:452-57
6. Malhotra R, Wormald MR, Rudd PM, Fischer PB, Dwek RA, Sim RB. 1995. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat. Med. 1:237-43
7. Rademacher TW, Parekh RB, Dwek RA. 1988. Glycobiology. Annu. Rev. Biochem. 57:785-838
8. Rudd PM, Guile GR, Kuster B, Harvey DJ, Opdenakker G, Dwek RA. 1997. Oligosaccharide sequencing technology. Nature 388:205-7
9. Rudd PM, Elliott T, Cresswell P, Wilson IA, Dwek RA. 2001. Glycosylation and the immune system. Science 291:2370-76
10. Bergeron JJ, Brenner MB, Thomas DY, Williams DB. 1994. Calnexin: a membrane-bound chaperone of the endoplasmic reticulum. Trends Biochem. Sci. 19:124-28
11. Scanlan CN, Pantophlet R, Wormald MR, Ollmann Saphire E, Stanfield R, et al. 2002. The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1→2 mannose residues on the outer face of gp120. J. Virol. 76:7306-21
12. Calarese DA, Scanlan CN, Zwick MB, Deechongkit S, Mimura Y, et al. 2003. Antibody domain exchange is an immunological solution to carbohydrate cluster recognition. Science 300:2065-71
13. Litman GW, Anderson MK, Rast JP. 1999. Evolution of antigen binding receptors. Annu. Rev. Immunol. 17:109-47
14. Amzel LM, Poljak RJ. 1979. Three-dimensional structure of immunoglobulins. Annu. Rev. Biochem. 48:961-97
15. Mimura Y, Church S, Ghirlando R, Ashton PR, Dong S, et al. 2000. The influence of glycosylation on the thermal stability and effector function expression of human IgG1-Fc: properties of a series of truncated glycoforms. Mol. Immunol. 37:697-706
16. Gala FA, Morrison SL. 2002. The role of constant region carbohydrate in the assembly and secretion of human IgD and IgA1. J. Biol. Chem. 277:29005-11
17. Mimura Y, Sondermann P, Ghirlando R, Lund J, Young SP, et al. 2001. Role of oligosaccharide residues of IgG1-Fc in FcγRIIb binding. J. Biol. Chem. 276:45539-47
18. Dong X, Storkus WJ, Salter RD. 1999. Binding and uptake of agalactosyl IgG by mannose receptor on macrophages and dendritic cells. J. Immunol. 163:5427-34
19. Sutton BJ, Phillips DC. 1983. The three-dimensional structure of the carbohydrate within the Fc fragment of immunoglobulin G. Biochem. Soc. Trans. 11(Pt. 2):130-32
20. Saphire EO, Stanfield RL, Crispin MD, Parren PW, Rudd PM, et al. 2002. Contrasting IgG structures reveal extreme asymmetry and flexibility. J. Mol. Biol. 319:9-18
21. Butler M, Quelhas D, Critchley AJ, Carchon H, Hebestreit HF, et al. 2003. Detailed glycan analysis of serum glycoproteins of patients with congenital disorders of glycosylation indicates the specific defective glycan processing step and provides an insight into pathogenesis. Glycobiology 13:601-22
22. Jefferis R, Lund J, Mizutani H, Nakagawa H, Kawazoe Y, et al. 1990. A comparative study of the N-linked oligosaccharide structures of human IgG subclass proteins. Biochem. J. 268:529-37
23. Wormald MR, Rudd PM, Harvey DJ, Chang SC, Scragg IG, et al. 1997. Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides. Biochemistry 36:1370-80
24. Parekh R, Roitt I, Isenberg D, Dwek R, Rademacher T. 1988. Age-related galactosylation of the N-linked oligosaccharides of human serum IgG. J. Exp. Med. 167:1731-36
25. Dwek RA, Leatherbarrow RJ. 1983. Magnetic resonance studies on antibody combining sites. Period. Biol. 85 (Suppl. 2):21-29
26. Padlan EA. 1991. Biological significance of carbohydrate chains on monoclonal antibodies. Proc. Natl. Acad. Sci. USA 80:6632-36
27. Krapp S, Mimura Y, Jefferis R, Huber R, Sondermann P. 2003. Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity. J. Mol. Biol. 325:979-89
28. Lund J, Takahashi N, Pound JD, Goodall M, Jefferis R. 1996. Multiple interactions of IgG with its core oligosaccharide can modulate recognition by complement and human Fc gamma receptor I and influence the synthesis of its oligosaccharide chains. J. Immunol. 157:4963-69
29. Dorrington KJ, Bennich HH. 1978. Structure-function relationships in human immunoglobulin E. Immunol. Rev. 41:3-25
30. Baenziger J, Kornfeld S, Kochwa S. 1974. Structure of the carbohydrate units of IgE immunoglobulin. II. Sequence of the sialic acid-containing glycopeptides. J. Biol. Chem. 249:1897-903
31. Baenziger J, Kornfeld S, Kochwa S. 1974. Structure of the carbohydrate units of IgE immunoglobulin. I. Over-all composition, glycopeptide isolation, and structure of the high mannose oligosaccharide unit. J. Biol. Chem. 249:1889-96
32. Arnold JN, Radcliffe CM, Wormald MR, Royle L, Harvey DJ, et al. 2004. The glycosylation of human serum IgD and IgE and the accessibility of identified oligomannose structures for interaction with mannan-binding lectin. J. Immunol. 173:6831-40
33. Liu FT. 1993. S-type mammalian lectins in allergic inflammation. Immunol. Today 14:486-90
34. Woof JM, Kerr MA. 2004. IgA function - variations on a theme. Immunology 113:175-77
35. Kerr MA. 1990. The structure and function of human IgA. Biochem. J. 271:285-96
36. Roos A, Bouwman LH, van Gijlswijk-Janssen DJ, Faber-Krol MC, Stahl GL, Daha MR. 2001. Human IgA activates the complement system via the mannan-binding lectin pathway. J. Immunol. 167:2861-68
37. Delacroix DL, Dive C, Rambaud JC, Vaerman JP. 1982. IgA subclasses in various secretions and in serum. Immunology 47:383-85
38. Field MC, Amatayakul-Chantler S, Rademacher TW, Rudd PM, Dwek RA. 1994. Structural analysis of the N-glycans from human immunoglobulin A1: comparison of normal human serum immunoglobulin A1 with that isolated from patients with rheumatoid arthritis. Biochem. J. 299(Pt. 1):261-75
39. Mattu TS, Pleass RJ, Willis AC, Kilian M, Wormald MR, et al. 1998. The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosylation on Fc alpha receptor interactions. J. Biol. Chem. 273:2260-72
40. Baenziger J, Kornfeld S. 1974. Structure of the carbohydrate units of IgA1 immunoglobulin. I. Composition, glycopeptide isolation, and structure of the asparagine-linked oligosaccharide units. J. Biol. Chem. 249:7260-69
41. Endo T, Mestecky J, Kulhavy R, Kobata A. 1994. Carbohydrate heterogeneity of human myeloma proteins of the IgA1 and IgA2 subclasses. Mol. Immunol. 31:1415-22
42. Basset C, Devauchelle V, Durand V, Jamin C, Pennec YL, et al. 1999. Glycosylation of immunoglobulin A influences its receptor binding. Scand. J. Immunol. 50:572-79
43. Stockert RJ. 1995. The asialoglycoprotein receptor: relationships between structure, function, and expression. Physiol. Rev. 75:591-6 09
44. Johansen FE, Braathen R, Brandtzaeg P. 2001. The J chain is essential for polymeric Ig receptor-mediated epithelial transport of IgA. J. Immunol. 167:5185-92
45. Royle L, Roos A, Harvey DJ, Wormald MR, van Gijlswijk-Janssen D, et al. 2003. Secretory IgA N- and O-glycans provide a link between the innate and adaptive immune systems. J. Biol. Chem. 278:20140-53
46. Wiersma EJ, Collins C, Fazel S, Shulman MJ. 1998. Structural and functional analysis of J chain-deficient IgM. J. Immunol. 160:5979-89
47. Norderhaug IN, Johansen FE, Schjerven H, Brandtzaeg P. 1999. Regulation of the formation and external transport of secretory immunoglobulins. Crit. Rev. Immunol. 19:481-508
48. Lamm ME. 1997. Interaction of antigens and antibodies at mucosal surfaces. Annu. Rev. Microbiol. 51:311-40
49. Mantis NJ, Farrant SA, Mehta S. 2004. Oligosaccharide side chains on human secretory IgA serve as receptors for ricin. J. Immunol. 172:6838-45
50. Schroten H, Stapper C, Plogmann R, Kohler H, Hacker J, Hanisch FG. 1998. Fab-independent antiadhesion effects of secretory immunoglobulin A on S-fimbriated Escherichia coli are mediated by sialyloligosaccharides. Infect. Immun. 66:3971-73
51. Wold AE, Mestecky J, Tomana M, Kobata A, Ohbayashi H, et al. 1990. Secretory immunoglobulin A carries oligosaccharide receptors for Escherichia coli type 1 fimbrial lectin. Infect. Immun. 58:3073-77
52. Krugmann S, Pleass RJ, Atkin JD, Woof JM. 1997. Mutagenesis of J chain residues critical for IgA dimer assembly. Biochem. Soc. Trans. 25:323
53. Falk P, Roth KA, Boren T, Westblom TU, Gordon JI, Normark S. 1993. An in vitro adherence assay reveals that Helicobacter pylori exhibits cell lineage-specific tropism in the human gastric epithelium. Proc. Natl. Acad. Sci. USA 90:2035-39
54. Boren T, Falk P, Roth KA, Larson G, Normark S. 1993. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 262:1892-95
55. Phalipon A, Cardona A, Kraehenbuhl JP, Edelman L, Sansonetti PJ, Corthesy B. 2002. Secretory component: a new role in secretory IgA-mediated immune exclusion in vivo. Immunity 17:107-15
56. Van Boxel JA, Paul WE, Terry WD, Green I. 1972. Communications. IgD-bearing human lymphocytes. J. Immunol. 109:648-51
57. Sun Z, Almogren A, Furtado PB, Chowdhury B, Kerr MA, Perkins SJ. 2005. Semi-extended solution structure of human myeloma immunoglobulin D determined by constrained X-ray scattering. J. Mol. Biol. 353:155-73
58. Takahashi N, Tetaert D, Debuire B, Lin LC, Putnam FW. 1982. Complete amino acid sequence of the delta heavy chain of human immunoglobulin D. Proc. Natl. Acad. Sci. USA 79:2850-54
59. Mellis SJ, Baenziger JU. 1983. Structures of the oligosaccharides present at the three asparagine-linked glycosylation sites of human IgD. J. Biol. Chem. 258:11546-56
60. Vassilakos A, Michalak M, Lehrman MA, Wlliams DB. 1998. Oligosaccharide binding characteristics of the molecular chaperones calnexin and calreticulin. Biochemistry 37:3480-90
61. Zapun A, Petrescu SM, Rudd PM, Dwek RA, Thomas DY, Bergeron JJ. 1997. Conformation-independent binding of monoglucosylated ribonuclease B to calnexin. Cell 88:29-38
62. Ellgaard L, Molinari M, Helenius A. 1999. Setting the standards: quality control in the secretory pathway. Science 286:1882-88
63. Trombetta ES, Helenius A. 1998. Lectins as chaperones in glycoprotein folding. Curr. Opin. Struct. Biol. 8:587-92
64. Crispin MD, Ritchie GE, Critchley AJ, Morgan BP, Wilson IA, et al. 2004. Monoglucosylated glycans in the secreted human complement component C3: implications for protein biosynthesis and structure. FEBS Lett. 566:270-74
65. Wormald MR, Wooten EW, Bazzo R, Edge CJ, Feinstein A, et al. 1991. The conformational effects of N-glycosylation on the tailpiece from serum IgM. Eur. J. Biochem198:131-39
66. Baker MD, Wu GE, Toone WM, Murialdo H, Davis AC, Shulman MJ. 1986. Aregion of the immunoglobulin-mu heavy chain necessary for forming pentameric IgM. J. Immunol. 137:1724-28
67. Arnold JN, Wormald MR, Suter DM, Radcliffe CM, Harvey DJ, et al. 2005. Human serum IgM glycosylation: identification of glycoforms that can bind to mannan-binding lectin. J. Biol. Chem. 280:29080-87
68. Chapman A, Kornfeld R. 1979. Structure of the high mannose oligosaccharides of a human IgM myeloma protein. II. The minor oligosaccharides of high mannose glycopeptide. J. Biol. Chem. 254:824-28
69. Chapman A, Kornfeld R. 1979. Structure of the high mannose oligosaccharides of a human IgM myeloma protein. I. The major oligosaccharides of the two high mannose glycopeptides. J. Biol. Chem. 254:816-23
70. Monica TJ, Williams SB, Goochee CF, Maiorella BL. 1995. Characterization of the glycosylation of a human IgM produced by a human-mouse hybridoma. Glycobiology 5:175-85
71. Hamers-Casterman C, Wittouck E, van der Loo W, Hamers R. 1979. Phylogeny of the rabbit gamma-chain determinants: a d12-like antigenic determinant in Pronolagus rupestris. J. Immunogenet. 6:373-81
72. Mellis SJ, Baenziger JU. 1983. Structures of the O-glycosidically linked oligosaccharides of human IgD. J. Biol. Chem. 258:11557-63
73. Baenziger J, Kornfeld S. 1974. Structure of the carbohydrate units of IgA1 immunoglobulin. II. Structure of the O-glycosidically linked oligosaccharide units. J. Biol. Chem. 249:7270-81
74. Tarelli E, Smith AC, Hendry BM, Challacombe SJ, Pouria S. 2004. Human serum IgA1 is substituted with up to six O-glycans as shown by matrix assisted laser desorption ionisation time-of-flight mass spectrometry. Carbohydr. Res. 339:2329-35
75. Kilian M, Reinholdt J, Lomholt H, Poulsen K, Frandsen EV. 1996. Biological significance of IgA1 proteases in bacterial colonization and pathogenesis: critical evaluation of experimental evidence. Apmis 104:321-38
76. Reinholdt J, Tomana M, Mortensen SB, Kilian M. 1990. Molecular aspects of immunoglobulin A1 degradation by oral streptococci. Infect. Immun. 58:1186-94
77. Boehm MK, Woof JM, Kerr MA, Perkins SJ. 1999. The Fab and Fc fragments of IgA1 exhibit a different arrangement from that in IgG: a study by X-ray and neutron solution scattering and homology modelling. J Mol. Biol. 286:1421-47
78. Zhu D, McCarthy H, Ottensmeier CH, Johnson P, Hamblin TJ, Stevenson FK. 2002. Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma. Blood 99:2562-68
79. Chandrasekaran EV, Mendicino A, Garver FA, Mendicino J. 1981. Structures of sialylated O-glycosidically and N-glycosidically linked oligosaccharides in a monoclonal immunoglobulin light chain. J Biol. Chem. 256:1549-55
80. Wallick SC, Kabat EA, Morrison SL. 1988. Glycosylation of a VH residue of a monoclonal antibody against α(1→6) dextran increases its affinity for antigen. J. Exp. Med. 168:1099-09
81. Wright A, Tao MH, Kabat EA, Morrison SL. 1991. Antibody variable region glycosylation: position effects on antigen binding and carbohydrate structure. EMBO J. 10:2717-23
82. Taniguchi T, Mizuochi T, Beale M, Dwek RA, Rademacher TW, Kobata A. 1985. Structures of the sugar chains of rabbit immunoglobulin G: occurrence of asparagine-linked sugar chains in Fab fragment. Biochemistry 24:5551-57
83. Youings A, Chang SC, Dwek RA, Scragg IG. 1996. Site-specific glycosylation of human immunoglobulin G is altered in four rheumatoid arthritis patients. Biochem. J. 314(Pt. 2):621-30
84. Gala FA, Morrison SL. 2004. V region carbohydrate and antibody expression. J. Immunol. 172:5489-94
85. Radcliffe CM, Arnold JN, Suter DM, Wormald MR, Harvey DJ, et al. 2007. Human follicular lymphoma cells contain oligomannose glycans in the antigen-binding site of the B cell receptor. J. Biol. Chem. In press
86. Parekh RB, Tse AG, Dwek RA, Williams AF, Rademacher TW. 1987. Tissue-specific N-glycosylation, site-specific oligosaccharide patterns and lentil lectin recognition of rat Thy-1. EMBO J. 6:1233-44
87. Rudd PM, Dwek RA. 1997. Glycosylation: heterogeneity and the 3D structure of proteins. Crit. Rev. Biochem. Mol. Biol. 32:1-100
88. Shields RL, Namenuk AK, Hong K, Meng YG, Rae J, et al. 2001. High resolution mapping of the binding site on human IgG1 for FcγRI, FcγRII, FcγRIII, and FcRn and design of IgG1 variants with improved binding to the FcγR. J. Biol. Chem. 276:6591-604
89. Jefferis R, Lund J. 2002. Interaction sites on human IgG-Fc for FcγR: current models. Immunol. Lett. 82:57-65
90. Okazaki A, Shoji-Hosaka E, Nakamura K, Wakitani M, Uchida K, et al. 2004. Fucose depletion from human IgG1 oligosaccharide enhances binding enthalpy and association rate between IgG1 and FcγRIIIa. J. Mol. Biol. 336:1239-49
91. Ferrara C, Stuart F, Sondermann P, Brunker P, Umana P. 2006. The carbohydrate at FcγRIIIa Asn-162. An element required for high affinity binding to non-fucosylated IgG glycoforms. J. Biol. Chem. 281:5032-36
92. Rudd PM, Fortune F, Patel T, Parekh RB, Dwek RA, Lehner T. 1994. A human T-cell receptor recognizes 'O'-linked sugars from the hinge region of human IgA1 and IgD. Immunology 83:99-106
93. Amin AR, Tamma SM, Oppenheim JD, Finkelman FD, Kieda C, et al. 1991. Specificity of the murine IgD receptor on T cells is for N-linked glycans on IgD molecules. Proc. Natl. Acad. Sci. USA 88:9238-42
94. Preud'homme JL, Petit I, Barra A, Morel F, Lecron JC, Lelievre E. 2000. Structural and functional properties of membrane and secreted IgD. Mol. Immunol. 37:871-87
95. Spiegelberg HL, Boltz-Nitulescu G, Plummer JM, Melewicz FM. 1983. Characterization of the IgE Fc receptors on monocytes and macrophages. Fed. Proc. 42:124-28
96. Capron M, Capron A, Dessaint JP, Torpier G, Johansson SG, Prin L. 1981. Fc receptors for IgE on human and rat eosinophils. J. Immunol. 126:2087-92
97. Gonzalez-Molina A, Spiegelberg HL. 1977. A subpopulation of normal human peripheral B Iymphcytes that bind IgE. J. Clin. Invest. 59:616-24
98. Yodoi J, Ishizaka K. 1979. Lymphocytes bearing Fc receptors for IgE. I. Presence of human and rat T lymphocytes with Fc epsilon receptors. J. Immunol. 122:2577-83
99. Sutton BJ, Gould HJ. 1993. The human IgE network. Nature 366:421-28
100. Bettler B, Maier R, Ruegg D, Hofstetter H. 1989. Binding site for IgE of the human lymphocyte low-affinity Fcereceptor (FcεRII/CD23) is confined to the domain homologous with animal lectins. Proc. Natl. Acad. Sci. USA 86:7118-22
101. Vercelli D, Helm B, Marsh P, Padlan E, Geha RS, Gould H. 1989. The B-cell binding site on human immunoglobulin E. Nature 338:649-51
102. Richards ML, Katz DH. 1990. The binding of IgE to murine FcεRII is calcium-dependent but not inhibited by carbohydrate. J. Immunol. 144:2638-46
103. Bjorklund JE, Karlsson T, Magnusson CG. 1999. N-glycosylation influences epitope expression and receptor binding structures in human IgE. Mol. Immunol. 36:213-21
104. Fortune F, Kingston J, Barnes CS, Lehner T. 1990. Identification and characterization of IgA and Vicia villosa-binding T cell subsets in rheumatoid arthritis. Clin. Exp. Immunol. 79:202-8
105. Moura IC, Arcos-Fajardo M, Sadaka C, Leroy V, Benhamou M, et al. 2004. Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy. J. Am. Soc. Nephrol. 15:622-34
106. Moura IC, Centelles MN, Arcos-Fajardo M, Malheiros DM, Collawn JF, et al. 2001. Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy. J. Exp. Med. 194:417-25
107. Rook GA, Steele J, Brealey R, Whyte A, Isenberg D, et al. 1991. Changes in IgG glycoform levels are associated with remission of arthritis during pregnancy. J. Autoimmun. 4:779-94
108. Rademacher TW, Williams P, Dwek RA. 1994. Agalactosyl glycoforms of IgG autoantibodies are pathogenic. Proc. Natl. Acad. Sci. USA 91:6123-27
109. Parekh R, Isenberg D, Rook G, Roitt I, Dwek R, Rademacher T. 1989. A comparative analysis of disease-associated changes in the galactosyladon of serum IgG. J. Autoimmun. 2:101-14
110. Bond A, Alavi A, Axford JS, Bourke BE, Bruckner FE, et al. 1997. A detailed lectin analysis of IgG glycosylation, demonstrating disease specific changes in terminal galactose and N-acetylglucosamine. J. Autoimmun. 10:77-85
111. Omtvedt LA, Royle L, Husby G, Sletten K, Radcliffe CM, et al. 2006. Glycan analysis of monoclonal antibodies secreted in deposition disorders indicates that subsets of plasma cells differentially process IgG glycans. Arthritis Rheum. 54:3433-40
112. Axford JS, Mackenzie L, Lydyard PM, Hay FC, Isenberg DA, Roitt IM. 1987. Reduced B-cell galactosyltransferase activity in rheumatoid arthritis. Lancet 2:1486-88
113. Axford JS, Sumar N, Alavi A, Isenberg DA, Young A, et al. 1992. Changes in normal glycosylation mechanisms in autoimmune rheumatic disease. J. Clin. Invest. 89:1021-31
114. Garred P, Madsen HO, Marquart H, Hansen TM, Sorensen SF, et al. 2000. Two edged role of mannose binding lectin in rheumatoid arthritis: a cross sectional study. J. Rheumatol. 27:26-34
115. Conley ME, Cooper MD, Michael AF. 1980. Selective deposition of immunoglobulin A1 in immunoglobulin A nephropathy, anaphylactoid purpura nephritis, and systemic lupus erythematosus. J. Clin. Invest. 66:1432-36
116. Allen AC, Bailey EM, Brenchley PE, Buck KS, Barrati J, Feehally J. 2001. Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients. Kidney Int. 60:969-73
117. Mestecky J, Tomana M, Crowley-Nowick PA, Moldoveanu Z, Julian BA, Jackson S. 1993. Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy. Contrib. Nephrol. 104:172-82
118. Hiki Y, Odani H, Takahashi M, Yasuda Y, Nishimoto A, et al. 2001. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy. Kidney Int. 59:1077-85
119. Mestecky J, Hashim OH, Tomana M. 1995. Alterations in the IgA carbohydrate chains influence the cellular distribution of IgA1. Contrib. Nephrol. 111:66-71
120. Hiki Y, Iwase H, Kokubo T, Horii A, Tanaka A, et al. 1996. Association of asialogalactosyl beta 1-3N-acetylgalactosamine on the hinge with a conformational instability of Jacalin-reactive immunoglobulin A1 in immunoglobulin A nephropathy. J. Am. Soc. Nephrol. 7:955-60
121. Floege J, Feehally J. 2000. IgA nephropathy: recent developments. J. Am. Soc. Nephrol. 11:2395-403
122. Basset C, Durand V, Jamin C, Clement J, Pennec Y, et al. 2000. Increased N-linked glycosylation leading to oversialylation of monomeric immunoglobulin A1 from patients with Sjogren's syndrome. Scand. J. Immunol. 51:300-6
123. Zhu D, Ottensmeier CH, Du MQ, McCarthy H, Stevenson FK. 2003. Incidence of potential glycosylation sites in immunoglobulin variable regions distinguishes between subsets of Burkitt's lymphoma and mucosa-associated lymphoid tissue lymphoma. Br. J. Haematol. 120:217-22
124. Zdanov A, Li Y, Bundle DR, Deng SJ, MacKenzie CR, et al. 1994. Structure of a single-chain antibody variable domain (Fv) fragment complexed with a carbohydrate antigen at 1.7-Å resolution. Proc. Natl. Acad. Sci. USA 91:6423-27
125. Bundle DR, Eichler E, Gidney MA, Meldal M, Ragauskas A, et al. 1994. Molecular recognition of a Salmonella trisaccharide epitope by monoclonal antibody Se155-4. Biochemistry 33:5172-82
126. Nourel Din MS, Nibbeling R, Rotmans JP, Polderman AM, Krijger FW, Deelder AM. 1994. Quantitative determination of circulating soluble egg antigen in urine and serum of Schistosoma mansoni-infected individuals using a combined two-site enzyme-linked immunosorbent assay. Am. J. Trop. Med. Hyg. 50:585-94
127. Fernandez-Santana V, Cardoso F, Rodriguez A, Carmenate T, Pena L, et al. 2004. Antigenicity and immunogenicity of a synthetic oligosaccharide-protein conjugate vaccine against Haemophilus influenzae type b. Infect. Immun. 12:7115-23
128. Trkola A, Purtscher M, Muster T, Ballaun C, Buchacher A, et al. 1996. Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. J. Virol. 70:1100-8
129. Umana P, JeaN-Mairet J, Moudry R, Amstutz H, Bailey JE. 1999. Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity. Nat. Biotechnol. 17:176-80
130. Lifely MR, Hale C, Boyce S, Keen MJ, Phillips J. 1995. Glycosylation and biological activity of CAMPATH-1H expressed in different cell lines and grown under different culture conditions. Glycobiology 5:813-22
131. Hamilton SR, Bobrowicz P, Bobrowicz B, Davidson RC, Li H, et al. 2003. Production of complex human glycoproteins in yeast. Science 301:1244-46
132. Bolt S, Routledge E, Lloyd I, Chatenoud L, Pope H, et al. 1993. The generation of a humanized, non-mitogenic CD3 monoclonal antibody which retains in vitro immunosuppressive properties. Eur. J. Immunol. 23:403-11
133. Friend PJ, Hale G, Chatenoud L, Rebello P, Bradley J, et al. 1999. Phase I study of an engineered aglycosylated humanized CD3 antibody in renal transplant rejection. Transplantation 68:1632-37
134. Larrick JW, Yu L, Naftzger C, Jaiswal S, Wycoff K. 2001. Production of secretory IgA antibodies in plants. Biomol. Eng. 18:87-94
135. Hood EE, Woodard SL, Horn ME. 2002. Monoclonal antibody manufacturing in transgenic plants - myths and realities. Curr. Opin. Biotechnol. 13:630-35
136. Ko K, Tekoah Y, Rudd PM, Harvey DJ, Dwek RA, et al. 2 003. Function and glycosylation of plant-derived antiviral monoclonal antibody. Proc. Natl. Acad. Sci. USA 100:8013-18
137. Joshi L, Lopez LC. 2005. Bioprospecting in plants for engineered proteins. Curr. Opin. Plant. Biol. 8:223-26
138. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, et al. 2000. The Protein Data Bank. Nucleic Acids Res. 28:235-42
139. Stanfield RL, Fieser TM, Lerner RA, Wilson IA. 1990. Crystal structures of an antibody to a peptide and its complex with peptide antigen at 2.8 Å. Science 248:712-19
140. Wan T, Beavil RL, Fabiane SM, Beavil AJ, Sohi MK, et al. 2002. The crystal structure of IgE Fc reveals an asymmetrically bent conformation. Nat. Immunol. 3:681-86
141. Garman SC, Wurzburg BA, Tarchevskaya SS, Kinet JP, Jardetzky TS. 2000. Structure of the Fc fragment of human IgE bound to its high-affinity receptor FcεRIα. Nature 406:259-66
142. Guile GR, Rudd PM, Wing DR, Prime SB, Dwek RA. 1996. A rapid high-resolution high-performance liquid chromatographic method for separating glycan mixtures and analyzing oligosaccharide profiles. Anal. Biochem. 240:210-26
143. Van den Steen PE, Rudd PM, Dwek RA, Opdenakker G. 1998. Concepts and principles of O-linked glycosylation. Crit. Rev. Biochem. Mol. Biol. 33:151-208